Traws Pharma (TRAW) Revenue (2012 - 2025)

Traws Pharma (TRAW) has reported Revenue for 14 consecutive years, with $2.7 million the latest figure, recorded in Q2 2025.

• On a quarterly basis, Revenue rose 4694.74% year-over-year to $2.7 million in Q2 2025; TTM through Dec 2025 was $2.8 million, a 1134.51% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 1134.51% from the prior year.
• Revenue was $2.7 million for Q2 2025 at Traws Pharma, up from $57000.0 in the prior quarter.
• Over five years, Revenue peaked at $2.7 million in Q2 2025 and troughed at $56000.0 in Q1 2021.
• A 5-year average of $205222.2 and a median of $57000.0 in 2021 frame the typical range for Revenue.
• Across the five-year window, Revenue slipped 13.64% in 2021 and jumped 4694.74% in 2025, its largest moves.
• Over 5 years, Revenue stood at $56000.0 in 2021, then changed by 0.0% to $56000.0 in 2022, then changed by 0.0% to $56000.0 in 2023, then changed by 0.0% to $56000.0 in 2024, then jumped by 4780.36% to $2.7 million in 2025.
• The last three Revenue figures came in at $2.7 million (Q2 2025), $57000.0 (Q1 2025), and $56000.0 (Q4 2024), per Business Quant data.